Akebia Therapeutics, Inc. (AKBA) vs Siga Technologies Inc. (SIGA)
- Akebia Therapeutics, Inc. AKBA 0.67 −4.29%
- Siga Technologies Inc. SIGA 3.17 −0.63%
Akebia Therapeutics, Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Siga Technologies Inc. is the larger, with a market value of $229.2M against $192.7M — 1.2× the size. Akebia Therapeutics, Inc. grew revenue faster over the last twelve months: 7.52% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −13.5%) and the lower return on invested capital (−14.6% vs 0.00%). Across the 19 metrics below, Akebia Therapeutics, Inc. leads on 11 and Siga Technologies Inc. on 8.
Valuation
Profitability
| Metric | AKBA | SIGA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 79.63% | 54.35% | 53.94% |
| Operating margin | (6.90%) | (20.76%) | 0.00% |
| Net margin | (13.54%) | (5.19%) | 0.00% |
| Free cash flow margin | 18.38% | (37.58%) | 0.00% |
| Return on equity | (109.38%) | (1.49%) | (0.40%) |
| Return on assets | (8.53%) | (1.36%) | (3.32%) |
| Return on invested capital | 0.00% | (14.59%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack